Multimetric synergy analysis of WEE1 inhibitor adavosertib with DNA-damaging drugs identifies candidate therapeutic windows in a triple-negative breast cancer cell line model

ASPET Discovery · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles